Korean J Gastroenterol.  1997 Jun;29(6):727-733.

Antimicrobial Resistances of Helicobacter pylori in Korean Patients with Duodenal Ulcer

Abstract

BACKGROUND/AIMS: Clarithromycin and metronidazole are most frequently used antibiotics for eradication of H. pylori infection. Primary resistance to metronidazole is high in some populations. Success of H. pylori eradication therapy may be limited by antibiotic resistance. In this study we evaluate primary resistance of clarithromycin and metronidazole in Korean duodenal ulIcer patients.
METHODS
H. pylori isolated from gastric biopsies of patients with newly diagnosed duodenal ulcer were cultured in egg yolk emulsion agar, brain heart infusion broth and tested for clarithromycin and metronidazole resistance by microdilution broth, E test(AB Biodisk, Solna, Sweden) and disk diffusion methods. The breakpoint MIC for Spg/mL in metronidazole, 2pg/mL and 12mm in clarithromycin. The patients with previous trip]e therapy were excluded.
RESULTS
One of 40(2%) isolates was resistant to clarithromycin in microdilution broth, E test, and disk diffusion methods. Metronidazole resistance were 22/40(55%) in microdilution rnethod(9/22 had MICs w 32pg/mL), 26 of 40(65%) in E test(19/26 had MICs >32pg/mL), 25 of 40(62.5%) in disk diffusion methods. Age, sex and smoking did not influence on the results.
CONCLUSIONS
Metronidazole resistance is high(55%) in Korea, but clarithromycin resistance is relatively low, therefore proper antimicrobial treatrnent should be considered in regard to antibiotic susceptibility test to H. pylori.

Keyword

Helicobacter pylori; Resistance; Metronidazole; Clarithromycin

MeSH Terms

Agar
Anti-Bacterial Agents
Biopsy
Brain
Clarithromycin
Diffusion
Drug Resistance, Microbial
Duodenal Ulcer*
Egg Yolk
Heart
Helicobacter pylori*
Helicobacter*
Humans
Korea
Metronidazole
Smoke
Smoking
Agar
Anti-Bacterial Agents
Clarithromycin
Metronidazole
Smoke
Full Text Links
  • KJG
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr